Raveling Chiropractic Center, P.A., Treats Plantar Fasciitis

Dec 06, 2015 15:00 pm UTC| Business

DUNEDIN, Fla., Dec. 06, 2015 (GLOBE NEWSWIRE) -- Raveling Chiropractic Center, P.A., treats the foot condition known as plantar fasciitis. Plantar fasciitis is a condition that can affect one foot or both feet at once....

Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease

Dec 06, 2015 14:00 pm UTC| Business

Results to be Presented During an Oral Session at the American Society of Hematology (ASH) Annual Meeting and Exposition Tomorrow, December 7 at 10:45 a.m. ET Company to Host Webcast Tomorrow at 12:30 p.m. ET to Discuss...

Atara Bio Announces Positive Results From a Phase 2 Clinical Trial of Cytomegalovirus Targeted Cytotoxic T Lymphocytes (CMV-CTL), a Novel Approach to Adoptive Immunotherapy, to Treat Patients With Refractory CMV Disease in the Central Nervous System (CNS)

Dec 06, 2015 14:00 pm UTC| Business

Overall Response Rate 70% and no GvHD Observed in Patients with Refractory CMV Chorioretinitis or Meningoencephalitis Findings Reported at American Society of Hematology (ASH) Annual Meeting 2015 SOUTH SAN FRANCISCO,...

Business big hitters highlight the huge growth in climate risk management

Dec 06, 2015 05:08 am UTC| Insights & Views Business Politics

Investors are running ahead of governments. This is arguably the most striking and encouraging statement heard so far at the Paris climate conference. It was made in a remarkable speech at a forum on private financing...

Idera Pharmaceuticals Reports Positive Data From Ongoing Phase 1/2 Clinical Trial of IMO-8400 in Patients With Waldenstrom’s Macroglobulinemia

Dec 05, 2015 22:30 pm UTC| Business

ORLANDO, Fla., Dec. 05, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare...

Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology and Nomination of ACH-4471, a Novel Small Molecule Factor D Inhibitor, for Clinical Development

Dec 05, 2015 22:00 pm UTC| Business

- Presentation will highlight ACH-4471, a highly potent, specific, and orally-administered factor D inhibitor, and preclinical data on its ability to block hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) cells;...

Air Pollution Experts & Geologist to Meet With Porter Ranch Residents to Discuss Massive Porter Ranch Gas Leak

Dec 05, 2015 21:16 pm UTC| Business

LOS ANGELES, Dec. 05, 2015 (GLOBE NEWSWIRE) -- Attorney R. Rex Parris whose law firm filed an 85 page class action lawsuit on behalf of dozens of plaintiffs and Save Porter Ranch harmed by Southern California Gas...